Consolidating CCDs from multiple data sources: A modular approach
Conclusion Given increasing adoption and use of health information exchange (HIE) to share data and information across the care continuum, duplication of information is inevitable. A novel system designed to support automated consolidation and de-duplication of information across clinical documents as they are exchanged shows promise. Future work is needed to expand the capabilities of the system and further test it using heterogeneous vocabularies across multiple HIE scenarios.
This study aimed to identify the phenotype and immunologic findings in Korean children with barley allergy. METHODS: Forty-two participants with a history of ingesting barley who underwent serum specific immunoglobulin E to barley (barley-sIgE) assay at the Department of Pediatrics in Ajou Medical Center were enrolled through a retrospective analysis of medical records from March 2008 to February 2018. The demographic characteristics, symptoms, and immunologic parameters of the patients were assessed. RESULTS: Twenty subjects presented with clinical barley allergy (B-allergic group), and 22 were atopic controls w...
CONCLUSIONS: All patients with a suspected contact allergy should receive a guideline-based patch test at an early stage. Targeted patch testing identifies clinically relevant allergens and provides suggestions for further systematic investigations. PMID: 31950209 [PubMed - as supplied by publisher]
AbstractPurpose of ReviewBiologic agents are new treatment options for chronic inflammatory diseases and cancers. As a result of their unique mechanism of action, they are more effective and less toxic treatment option and their clinical usage is increasing. While they are more commonly used, various adverse effects have been observed including life-threatening ones, including anaphylaxis. The aim of this review is to distinguish the anaphylaxis from other hypersensitivity reactions (HSR) and provide a management algorithm for the anaphylactic reactions induced by biological agents.Recent FindingsMany case reports and seri...
Publication date: Available online 16 January 2020Source: The Journal of Allergy and Clinical Immunology: In PracticeAuthor(s): Matthew S. Krantz, Yiwei Liu, Elizabeth J. Phillips, Cosby A. Stone
Symptom-based health screening of passengers entering the US on direct or connecting flights from Wuhan, China, will be conducted in San Francisco, New York, and Los Angeles.Medscape Medical News
Palmer Candy Company (www.palmercandy.com), announced today a limited recall of Sea Salt Caramel Hearts that were only sold at Bomgaards Supply Inc. Store in the Midwest States. The voluntary recall, in cooperation with the U.S. Food and Drug Administration (FDA) due to abundance of caution of a possible peanut allergen contamination. People who have an allergy or severe sensitivity to peanuts run the risk of serious or life-threatening allergic reaction if they consume these products.
The monoclonal antibody bezlotoxumab reduces the rate of recurrent Clostridioides difficile infection, according to findings from the MODIFY II trial.Reuters Health Information
Mice have thousands of allergen-sensing nose cells, a discovery which may offer clues as to why some people with allergies lose their sense of smell
VISIBLE RESULTS ACHIEVED WITHIN 15 MINUTES OF APPLICATION DUBLIN, Jan. 17, 2020 -- (Healthcare Sales &Marketing Network) -- Allergan plc (NYSE: AGN) announced today the launch of the SkinMedica® Instant Bright Eye Cream, a refreshing eye treatment... Biopharmaceuticals, Dermatology, Product Launch Allergan, SkinMedica, Instant Bright Eye Cream